Actions Elicited by In-hospital Follow-up of Cardiac Devices (ATHENS)

February 2, 2011 updated by: Cliniche Humanitas Gavazzeni

Action Elicited By Scheduled In-Hospital Follow-Up of Cardiac Devices

This study will enroll all patients who will attend an in-hospital follow-up of cardiac device since February 22nd 2010 to June 21st 2010.

Primary objective of the study is to observe how many of patients seen during these period (approximately 5000) will receive a change in cardiac device programming or in drug therapy or a scheduled or urgent hospital admission.

These data should help to clarify how useful and safe is a remote monitoring strategy for this kind of patients.

Study Overview

Detailed Description

Number of Pacemakers (PM) and Implantable Cardioverter Defibrillators (ICD) is rapidly growing due to enlarged indications. This fact causes an exponential increase in scheduled in-hospital follow-ups. For this reason, all the companies that produce PM and ICD have released systems that allow remote monitoring and follow-up of cardiac devices (both PM and ICD) and U.S. guidelines have already been changed, in order to suggest remote follow-up of these devices at appropriated intervals.

Nevertheless, informations on actions taken during scheduled in-hospital follow-up are incomplete.

ATHENS study has been designed to answer to 3 questions:

  1. How often, during a scheduled in hospital follow-up physicians "change" something ? (device programming; drug therapy; scheduled device replacement ...)
  2. The "rate of change" is different is the follow-up is required pby the general practitioner who normally takes care of the patients or by the patient itself?
  3. Change are more frequent during PM or during ICD follow-up or during cardiac resynchronization therapy devices?

Study Type

Observational

Enrollment (Actual)

3362

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bergamo, Italy, 24121
        • U.O. Aritmologia - Cliniche Humanitas Gavazzeni
      • Brescia, Italy, 25123
        • Laboratorio di Elettrofisiologia - Spedali Civili
      • Lecco, Italy, 23900
        • Laboratorio di Elettrofisiologia - Ospedale A. Manzoni
      • Mantova, Italy, 46100
        • Laboratorio di Elettrofisiologia - Ospedale Carlo Poma
      • Pavia, Italy, 27100
        • Laboratorio di Elettrofisiologia - Ospedale San Matteo
    • Brescia
      • Desenzano del Garda, Brescia, Italy, 25015
        • Laboratorio di Elettrofisiologia
    • Cremona
      • Casalmaggiore, Cremona, Italy, 26041
        • Laboratorio di Cardiologia - Ospedale Civile
    • Lecco
      • Merate, Lecco, Italy, 23807
        • Laboratorio di Elettrofisiologia

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

All patients who will undergo an in-hospital follow-up of a cardiac device

Description

Inclusion Criteria:

  • All patients with a cardiac device

Exclusion Criteria:

  • Follow-up of a cardiac device at discharge from hospital after first implant

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Cardiac device
All patients implanted with a cardiac device, pacemaker(PM)or Implantable Cardioverter Defibrillator (ICD)
Electrical measures taken during normal follow-up and clinical status of the patient

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Number of Patients of the Whole Population in Whom Something (Therapy, Device Programming ...) Has Been Changed During In-hospital Follow-up
Time Frame: 4 months
4 months

Secondary Outcome Measures

Outcome Measure
Time Frame
Number of Patients -Amongst Those Implanted With a Pacemaker - in Whom Something (Therapy, Device Programming ...) Has Been Changed During In-hospital Follow-up
Time Frame: 4 months
4 months
Number of Patients - Amongst Those Implanted With an Implantable Cardioverter Defibrillator (ICD)- in Whom Something (Therapy, Device Programming ...) Has Been Changed During In-hospital Follow-up
Time Frame: 4 months
4 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Giosue Mascioli, MD, Cliniche Humanitas Gavazzeni
  • Study Chair: Antonio Curnis, MD, Spedali Civili di Brescia
  • Principal Investigator: Maurizio Landolina, MD, Policlinico San Matteo Pavia
  • Principal Investigator: Gian-Paolo Gelmini, MD, Ospedale Civile di Desenzano d/Garda
  • Principal Investigator: Franco Ruffa, MD, Ospedale A. Manzoni - Lecco

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2010

Primary Completion (Actual)

January 1, 2011

Study Completion (Actual)

January 1, 2011

Study Registration Dates

First Submitted

February 22, 2010

First Submitted That Met QC Criteria

February 22, 2010

First Posted (Estimate)

February 23, 2010

Study Record Updates

Last Update Posted (Estimate)

February 28, 2011

Last Update Submitted That Met QC Criteria

February 2, 2011

Last Verified

January 1, 2011

More Information

Terms related to this study

Other Study ID Numbers

  • GAVBS1

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiac Pacemaker, Artificial

Clinical Trials on In-hospital follow-up of cardiac device

3
Subscribe